Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Endo International PLC

www.endo.com

Latest From Endo International PLC

Endo And Allergan Could Edge Out Of Opioid Bellwether Trial Spotlight With Proposed Settlements

Companies reach agreements in principal with plaintiffs in bellwether trial in the US multidistrict litigation as court date nears; plaintiffs narrow their claims from 11 to seven.
Legal Issues Advertising, Marketing & Sales

Endo Sees Strong Prospects For Hybrid Injectables Pipeline

Endo has high hope for its pipeline of 505(b)(2) hospital and critical-care drugs in the US as the group looks to return to revenue growth.

Value-Added Medicines Business Strategies

Opioid Exposure Risk Intensifying For Generic Drug Makers

Business fundamentals took a back seat to opioid litigation in the second quarter for generic drug makers, including Teva, Mallinckrodt and Endo Pharmaceuticals.

Generic Drugs Legal Issues

Vasopressin Ruling May Greenlight More FDA Limits On Bulk Drug Compounding

By siding with the FDA against bulk compounding of vasopressin, is court encouraging more limits to Section 503B outsourcing facilities?

Manufacturing Quality
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register